Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rakez Kayed

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
The Journal of Biological Chemistry|July 4, 2021
Infectious etiology and amyloidosis in Alzheimer's disease: The puzzle continuesRakez Kayed
Human Vaccines|October 29, 2010
Anti-tau oligomers passive vaccination for the treatment of Alzheimer diseaseRakez Kayed
Progress in Neurobiology|April 21, 2022
Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseasesUrmi Sengupta, Rakez Kayed
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2018
Amyloid oligomer interactions and polymorphisms: disease-relevant distinct assembly of α-synuclein and tauUrmi Sengupta, Rakez Kayed
Methods in Molecular Biology (Clifton, N.J.)|March 21, 2024
Tau Oligomers as Pathogenic Seeds: Preparation, Characterization, and Propagation In Vitro and In VivoUrmi Sengupta, Rakez Kayed
Current Pharmaceutical Design|May 19, 2016
Therapeutic Approaches Targeting Pathological Tau AggregatesJulia Gerson, Rakez Kayed
Cell Reports. Medicine|May 18, 2022
Quantification and targeting of elusive neurotoxic amyloid oligomersNemil Bhatt, Rakez Kayed
Current Opinion in Immunology|June 2, 2009
Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disordersRakez Kayed, George R Jackson
Methods in Enzymology|October 19, 2006
Conformation-dependent anti-amyloid oligomer antibodiesRakez Kayed, Charles G Glabe
Frontiers in Neurology|July 25, 2013
Formation and propagation of tau oligomeric seedsJulia E Gerson, Rakez Kayed
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
The Journal of Biological Chemistry|July 4, 2021
Infectious etiology and amyloidosis in Alzheimer's disease: The puzzle continuesRakez Kayed
Human Vaccines|October 29, 2010
Anti-tau oligomers passive vaccination for the treatment of Alzheimer diseaseRakez Kayed
Progress in Neurobiology|April 21, 2022
Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseasesUrmi Sengupta, Rakez Kayed
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2018
Amyloid oligomer interactions and polymorphisms: disease-relevant distinct assembly of α-synuclein and tauUrmi Sengupta, Rakez Kayed
Methods in Molecular Biology (Clifton, N.J.)|March 21, 2024
Tau Oligomers as Pathogenic Seeds: Preparation, Characterization, and Propagation In Vitro and In VivoUrmi Sengupta, Rakez Kayed
Current Pharmaceutical Design|May 19, 2016
Therapeutic Approaches Targeting Pathological Tau AggregatesJulia Gerson, Rakez Kayed
Cell Reports. Medicine|May 18, 2022
Quantification and targeting of elusive neurotoxic amyloid oligomersNemil Bhatt, Rakez Kayed
Current Opinion in Immunology|June 2, 2009
Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disordersRakez Kayed, George R Jackson
Methods in Enzymology|October 19, 2006
Conformation-dependent anti-amyloid oligomer antibodiesRakez Kayed, Charles G Glabe
Frontiers in Neurology|July 25, 2013
Formation and propagation of tau oligomeric seedsJulia E Gerson, Rakez Kayed
Pageof 21